Medtronic completes spin‑off of MiniMed, ending its equity stake

Medtronic exchanged its remaining 252,813,348 MiniMed shares for 55,032,401 Medtronic ordinary shares, finalising the separation of MiniMed Group. The exchange offer was 5.4 times subscribed. MiniMed is now an independent publicly‑traded company focused on diabetes care, while Medtronic will concentrate on its cardiovascular, neuroscience and surgical portfolios.

The company notes that the spin‑off allows Medtronic to focus on its core businesses and that investors should monitor MiniMed’s standalone financial results and trading debut.

  • 1Medtronic exchanged 252,813,348 MiniMed shares for 55,032,401 Medtronic ordinary shares.
  • 2The exchange offer was 5.4 times subscribed.
  • 3The offer’s proration factor was 18.289133 %.
  • 4MiniMed became an independent company and began trading on Nasdaq under the ticker MMED.
  • 5Medtronic will focus on its Cardiovascular, Neuroscience and Surgical portfolios after the separation.

Sources